Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-18 Sale | 2026-08-20 4:10 pm | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 101 | $2.01 | $203 | 18,033 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-18 Option Award | 2026-05-20 4:31 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 14,227 | $0 | 18,134 (Direct) | View |
| 2026-05-14 Tax Withholding | 2026-05-18 4:11 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $1.92 | 3,907 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 4:22 pm | N/A 2036-02-29 | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 31,900 | $0 | 31,900 (Direct) | View |
| 2026-02-14 Tax Withholding | 2026-02-18 4:14 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 116 | $1.63 | 4,006 (Direct) | View |
| 2025-11-14 Tax Withholding | 2025-11-18 4:33 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $2.24 | 4,122 (Direct) | View |
| 2025-08-14 Tax Withholding | 2025-08-18 5:19 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $1.39 | 4,221 (Direct) | View |
| 2025-05-14 Tax Withholding | 2025-05-16 4:21 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $1.14 | 4,320 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 5:36 pm | N/A 2035-02-28 | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 31,900 | $0 | 31,900 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 5:00 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 116 | $5.42 | 4,419 (Direct) | View |
| 2024-11-14 Tax Withholding | 2024-11-18 4:32 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $7.92 | 4,535 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:53 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $7.02 | 4,634 (Direct) | View |
| 2024-05-14 Tax Withholding | 2024-05-16 7:05 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $8.36 | 4,733 (Direct) | View |
Ownership | 2024-05-16 6:52 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 0 | $0 | 95,328 (Direct) | View |